KV Pharmaceutical to Host Conference Call Tuesday December 23, 4:30 pm ET

Wednesday, December 24, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

ST. LOUIS, Dec. 23 KV Pharmaceutical Company(NYSE: KV-A) will hold an analyst conference call at 4:30 p.m. EST (3:30 p.m.CST) today to discuss the announcement of a voluntary suspension of shipmentsof approved tablet form drugs.

A live webcast of the conference call will be available to all investorsat the KV Pharmaceutical Web site at http://www.kvpharmaceutical.com or at:http://w.on24.com/r.htm?e=130807&s=1&k=1085A5A957497D0BBDD698E02E17DCAF

For those who cannot listen to the live broadcast, an audio replay of thecall will be available on these Web sites until March 25, 2009.

About KV Pharmaceutical Company

KV Pharmaceutical Company is a fully integrated specialty pharmaceuticalcompany that develops, manufactures, markets, and acquires technology-distinguished branded and generic/non-branded prescription pharmaceuticalproducts. The company markets its technology distinguished products throughETHEX Corporation, a national leader in pharmaceuticals that compete withbranded products, and Ther-Rx Corporation, its branded drug subsidiary.

SOURCE KV Pharmaceutical Company


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook